Coriolis Pharma to Invest $10 Million in New North Carolina Laboratory
Introduction:
Coriolis Pharma has announced a $10 million investment to establish a new research laboratory in Morrisville, North Carolina. The move strengthens the company’s global footprint and brings its core formulation services closer to clients in the US biopharmaceutical market.
Features:
Establishment of a 13,000-square-foot state-of-the-art laboratory at Spark LS, a major life science campus in Morrisville
Creation of 50 new jobs in the region
Initial focus on particle identification services, followed by formulation development and lyophilisation
Full integration with Coriolis Pharma’s scientific and operational network in Germany
Designed to support future digital and in-silico technologies for biopharmaceutical development
Positioned within a thriving life sciences ecosystem near Research Triangle Park
Operations at the new site are expected to begin in the first quarter of 2026.
Specifications:
| Name | Coriolis Pharma |
| Budget | $10 Million |
| Type | Construction |
| Year of Beginning | First Quarter of 2026 |
